1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAdvancing Data Science Approaches to Address Health Disparities Through Artificial Intelligence (AI), and Machine Learning (ML), and Community-Engaged Research is sponsored by NIH Institutes, Centers, and Offices (ICOs). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Get emailed when new opportunities from “NIH Institutes, Centers, and Offices (ICOs)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Advancing Data Science Approaches to Address Health Disparities Through Artificial Intelligence (AI), and Machine Learning (ML), and Community-Engaged Research | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Advancing Data Science Approaches to Address Health Disparities Through Artificial Intelligence (AI), and Machine Learning (ML), and Community-Engaged Research When beginning your next investigator-initiated application, consider the following NIH highlighted topic.
The area of science described below is of interest to the listed NIH Institutes, Centers, and Offices (ICOs). This is not a notice of funding opportunity (NOFO). Apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity available on Grants.
gov . Learn how to interpret and use Highlighted Topics . Expiration Date: July 20, 2028 Purpose: this topic will support the development, implementation, and evaluation of community-engaged AI/ML interventions that convert routinely collected clinical and community-linked data into timely actions to improve screening completion, treatment adherence, disease control, and continuity of care in populations experiencing health disparities.
AI/ML is sufficiently advanced to support community-engaged interventions for populations experiencing health disparities. These models are most useful when used to activate specific, measurable actions rather than autonomous clinical decisions.
Recent advances in electronic health record (EHR)-based prediction, natural language processing, multimodal data integration, and mobile and remote monitoring makes it feasible to identify patients at high short-term risk of missed screening, uncontrolled chronic disease, medication interruption, avoidable acute care use, and loss to follow-up The strongest near-term opportunity is not diagnosis alone, but interventions targeting the right person to the right outreach, service, and follow-up at the right time.
For health disparities science, AI/ML should be embedded in clinical and/or community settings where implementation can improve uptake of evidence-based care.
High-value use cases include, but are not limited to: Using clinic, pharmacy, and remote monitoring data to prompt community health worker outreach for uncontrolled hypertension Identifying patients overdue for colorectal, cervical, or breast cancer screening and routing them to mailed or mobile screening options Predicting diabetes treatment interruption and prompting refill support, nutrition counseling, and home glucose monitoring Flagging pregnancy and postpartum patients at rising risk for hypertension, depression, or missed visits to activate nurse navigation and telehealth follow-up.
The main question is no longer whether AI/ML can generate accurate predictions in retrospective datasets. The critical question is whether engaging community in AI/ML systems can improve real-world outcomes when prospectively integrated into care delivery, and workflows that community organizations and health systems can sustain.
Research should therefore move beyond model development alone and test complete intervention pathways on whether outcomes improve, including: Which predictions are actionable? What service is triggered? Also of interest are use cases with short feedback loops, clear operational workflows, and measurable clinical endpoints.
National Institute on Minority Health and Health Disparities (NIMHD) NIMHD seeks co-designed interventions with patients, community organizations, federally qualified health centers (FQHCs), health systems, and public health partners – and use cases with evidence-based treatments and modifiable care gaps.
Research is needed to: Build and locally validate AI/ML models to predict near-term actionable events (e.g., uncontrolled blood pressure or HbA1c, postpartum loss, asthma exacerbation, and HIV care discontinuity) Link predictions to predefined action bundles such as community health worker outreach, scheduling assistance, mailed testing, telehealth follow-up, refill assistance, home monitoring, or specialist referral; Test interventions in prospective trials across clinics and partner organizations and produce implementation-ready tools for scale-up.
Measures may include clinical outcomes, uptake, disparity reduction, cost, and sustainability. IC may dedicate funds available to support applications in this Topic area depending upon the availability of funds, the number of meritorious applications, and competing ICO priorities. IC may give special consideration to support meritorious applications in this topic area.
Division of Clinical and Health Services Research National Institute of Mental Health (NIMH) NIMH seeks solutions-oriented AI/ML interventions in clinical/community settings to improve mental health (MH) management in populations experiencing health disparities, including people living with HIV and/or experiencing suicidal ideation and behavior.
Use of AI/ML tools to expand access to evidence-based interventions (EBI) and engage high-risk individuals, enhance provider training, analyze wearable/tracking data for early detection of prodrome signs, worsening symptoms, missed visits, medication nonadherence, crisis care use, or care disengagement, and support evidence-based follow-up Improve MH management in patients at risk of disengagement, treatment interruption, virologic non-suppression, or poor adherence through outreach and patient-caregiver connectivity Integrate AI/ML approaches to address co-occurring MH/HIV needs shaped by clinical, behavioral, social, and community factors Advance implementation and utilization of EBIs in community settings Lori A.
J. Scott-Sheldon, Ph. D.
Office of Behavioral and Social Sciences Research (OBSSR) This office does not award grants. Applications must be relevant to the objectives of at least one of the participating Institutes or Centers listed in this topic. Office of Disease Prevention (ODP) This office does not award grants.
Applications must be relevant to the objectives of at least one of the participating Institutes or Centers listed in this topic. For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Not explicitly stated, but implies researchers and organizations focused on health disparities. Confirm the full requirements in the official notice before applying.
Applications for Advancing Data Science Approaches to Address Health Disparities Through Artificial Intelligence (AI), and Machine Learning (ML), and Community-Engaged Research are due July 20, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Advancing Data Science Approaches to Address Health Disparities Through Artificial Intelligence (AI), and Machine Learning (ML), and Community-Engaged Research is funded by NIH Institutes, Centers, and Offices (ICOs). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward interdisciplinary projects that leverage AI, machine learning, and advanced data science to address pressing questions in biomedical and public health research. It seeks to advance fundamental scientific and engineering contributions across disciplines to solve key health problems.
As of October 1, 2025, NIH no longer posts Notices of Funding Opportunity in the NIH Guide — Grants.gov is now the single official source (NOT-OD-25-143). The weekly Guide table-of-contents email that thousands of investigators relied on to discover funding no longer lists opportunities. Combined with the January 25, 2026 SciENcv certified-PDF requirement, the mechanics of finding and applying for NIH money have changed underneath everyone. Here is how to rebuild your discovery workflow so nothing slips through.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe NIH Director's New Innovator Award (DP2, RFA-RM-27-002) closes August 17, 2026, offering roughly 30 Early Stage Investigators up to $475,000 in direct costs a year for five years — $2.375 million total — to pursue bold ideas without the preliminary data a standard R01 demands. Here is how the High-Risk, High-Reward program actually evaluates applications, who qualifies, and why the usual R01 instincts will sink you.
Read article